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ComorbiditiesPsychogenic nonepileptic seizures (PNES) are relatively com-
mon occurrences in epilepsy centers [1]. These seizures consist of
paroxysmal changes in responsiveness, movements, or behavior
that superﬁcially resemble epileptic seizures, but lack a neurobio-
logical origin as in epileptic seizures and are not associated with
electrophysiological epileptic changes [1]. It is clear that PNES lack
a neurobiological origin similar to epileptic seizures, but it seems
that there is a neurobiological basis for these events. Psychogenic
nonepileptic seizures may be the result of neurobiological
dysfunctions at speciﬁc brain networks and derangements in
structural and functional brain connectivity of speciﬁc areas [2,3].
As intrinsic brain abnormalities and dysfunctions are being
suggested in the pathophysiology of PNES, it is not irrational to
presume that genetic factors may play a role. However, there is no
paper in the literature investigating or even suggesting this
hypothesis.
The most obvious genetically determined risk factor for the
development of PNES is gender [4]. There is a predominance of
female gender among patients with PNES [1]. The reason for this
gender predominance is not clear yet. Besides, patients with PNES
often have psychiatric comorbidities. A lifetime history of other
somatoform or dissociative disorders is found in more than 50% of
patients who have PNES. Anxiety or psychotic and bipolar
disorders are less common but are found more frequently in
patients who have PNES than in the general population [4].
Interestingly, genetic factors play a signiﬁcant role in most of the
above comorbidities with PNES. In a recent study it was observed
that speciﬁc single-nucleotide polymorphisms (SNPs) are associ-
ated with a range of psychiatric disorders (i.e., autism spectrum
disorders, attention deﬁcit-hyperactivity disorder, bipolar disor-
der, major depressive disorder, and schizophrenia). In particular,
variation in calcium-channel activity genes seemed to have
pleiotropic effects on psychopathology. This analysis provided
the ﬁrst genome-wide evidence that individual and aggregatehttp://dx.doi.org/10.1016/j.seizure.2015.09.001
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psychiatric disorders. This ﬁnding, that genetic variants have
cross-disorder effects, is an empirical step toward helping
clinicians understand the common co-occurrence of psychiatric
clinical phenotypes in individual patients. This implicates a
speciﬁc biological pathway, voltage-gated calcium-channel sig-
naling, as a contributor to the pathogenesis of several psychiatric
disorders, and supports the potential of this pathway as a
therapeutic target for psychiatric diseases [5].
The relationship between genetic factors and PNES is obviously
multifactorial in nature, if proved to be existent; genetic and
environmental factors interactively determine their respective
pathomechanism. In other words, many other factors codetermine
whether PNES will develop in an individual, who supposedly has
genetic predisposition to develop PNES. Finding the genetic bases
and identiﬁcation of genetic biomarkers of PNES have potentially
important clinical implications in formulating better preventative,
diagnostic and therapeutic approaches. Many years of work on
treatment options for PNES have not made a great success in
helping these patients. Medications and psychotherapies help
some patients, but fail many others. Unfortunately, long-term
studies suggest that many patients with PNES will continue to
experience seizures despite neurological and psychotherapeutic
care [6]. Failures to improve efﬁcacy of treatment strategies in
patients with PNES may reﬂect continued ignorance of the cellular
and molecular mechanisms of PNES.
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